Suchergebnisse - "Bajel, Ashish"

PubPharm (117)

41

Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias

enthalten in: Blood | 2021

von Thijssen, R. | Diepstraten, S. | Moujalled, D. | +33

CommentIn: Blood. 2021 May 20;137(20):2711-2712. - PMID 34014291

42

Germline loss-of-function variants in the base-excision repair gene MBD4 cause a Mendelian recessive syndrome of adenomatous colorectal polyposis and acute myeloid leukaemia

enthalten in: bioRxiv.org | 2021

von Palles, C. | Chew, E. | Grolleman, J. | +57

43

Diagnosis of rare subtypes of acute myeloid leukaemia and related neoplasms

enthalten in: Pathology | 2021

von George, T. | Bajel, A.

44

An atypical case of Epstein–Barr virus‐positive plasma cell post‐transplant lymphoproliferative disorder successfully treated with adoptive cell therapy

enthalten in: British Journal of Haematology | 2021

von Elliott, J. | Avdic, S. | Selim, A. | +6

45

Australia and New Zealand Transplant and Cellular Therapies COVID‐19 vaccination consensus position statement

enthalten in: Internal Medicine Journal | 2021

von Hamad, N. | Ananda‐Rajah, M. | Gilroy, N. | +29

46

Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021

enthalten in: Internal Medicine Journal | 2021

von Douglas, A. | Smibert, O. | Bajel, A. | +6

47

Inotuzumab ozogamicin resistance associated with a novel CD22 truncating mutation in a case of B-acute lymphoblastic leukaemia

enthalten in: British journal of haematology | 2020

von Ryland, G. | Barraclough, A. | Fong, C. | +6

48

Severity of mucositis during allogeneic transplantation impacts post-transplant cyclosporin absorption

enthalten in: Bone marrow transplantation | 2020

von Tan, J. | Wong, E. | Bajel, A. | +3

49

Variable CD34+ recovery of cryopreserved allogeneic HPC products : transplant implications during the COVID-19 pandemic

enthalten in: Blood advances | 2020

von Purtill, D. | Antonenas, V. | Chiappini, P. | +14

50

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens : a CIBMTR report

enthalten in: Blood advances | 2020

von Zhou, Z. | Nath, R. | Cerny, J. | +82

ErratumIn: Blood Adv. 2021 Jul 13;5(13):2752. - PMID 34242389